GLP-1R Agonist
≥98% (HPLC)
- Product Code: 96767
CAS:
281209-71-0
| Molecular Weight: | 348.25 g./mol | Molecular Formula: | C₁₃H₁₅Cl₂N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
GLP-1R agonists are widely used in the management of type 2 diabetes due to their ability to enhance insulin secretion in a glucose-dependent manner. They help lower blood sugar levels by stimulating the release of insulin from pancreatic beta cells while simultaneously suppressing the secretion of glucagon, a hormone that raises blood glucose. Beyond glycemic control, these agonists are also effective in promoting weight loss, making them a valuable option for patients with obesity or overweight conditions. Additionally, they have shown cardiovascular benefits, reducing the risk of major adverse cardiovascular events in high-risk patients. GLP-1R agonists are administered via subcutaneous injection and are often prescribed as part of a comprehensive treatment plan that includes lifestyle modifications and other medications. Their ability to address multiple aspects of metabolic health has made them a cornerstone in diabetes care.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $586.50 |
+
-
|
GLP-1R Agonist
GLP-1R agonists are widely used in the management of type 2 diabetes due to their ability to enhance insulin secretion in a glucose-dependent manner. They help lower blood sugar levels by stimulating the release of insulin from pancreatic beta cells while simultaneously suppressing the secretion of glucagon, a hormone that raises blood glucose. Beyond glycemic control, these agonists are also effective in promoting weight loss, making them a valuable option for patients with obesity or overweight conditions. Additionally, they have shown cardiovascular benefits, reducing the risk of major adverse cardiovascular events in high-risk patients. GLP-1R agonists are administered via subcutaneous injection and are often prescribed as part of a comprehensive treatment plan that includes lifestyle modifications and other medications. Their ability to address multiple aspects of metabolic health has made them a cornerstone in diabetes care.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :